Showing results (611-620 of 735) with videos related to
Sort By:
Pageof 74
Human Molecular Genetics|November 28, 2012
Common variation at 2q22.3 (ZEB2) influences the risk of renal cancerMarc Henrion, Matthew Frampton, Ghislaine Scelo, et al.Nature Medicine|September 8, 2020
Avelumab plus axitinib versus sunitinib in advanced renal cell carcinoma: biomarker analysis of the phase 3 JAVELIN Renal 101 trialRobert J Motzer, Paul B Robbins, Thomas Powles, et al.Nature Cancer|May 22, 2023
The proteasome regulator PSME4 modulates proteasome activity and antigen diversity to abrogate antitumor immunity in NSCLCAaron Javitt, Merav D Shmueli, Matthias P Kramer, et al.Cancer Cell|April 22, 2023
Early immune pressure initiated by tissue-resident memory T cells sculpts tumor evolution in non-small cell lung cancerClare E Weeden, Velimir Gayevskiy, Claire Marceaux, et al.Cell|March 29, 2024
Embracing cancer complexity: Hallmarks of systemic diseaseCharles Swanton, Elsa Bernard, Chris Abbosh, et al.Nature|November 7, 2024
Origins and impact of extrachromosomal DNAChris Bailey, Oriol Pich, Kerstin Thol, et al.Nature Medicine|June 5, 2020
Publisher Correction: Pulmonary venous circulating tumor cell dissemination before tumor resection and disease relapseFrancesca Chemi, Dominic G Rothwell, Nicholas McGranahan, et al.Cell|July 22, 2025
Functional liver genomics identifies hepatokines promoting wasting in cancer cachexiaDoris Kaltenecker, Søren Fisker Schmidt, Peter Weber, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 31, 2023
Bempegaldesleukin Plus Nivolumab in Untreated Advanced Melanoma: The Open-Label, Phase III PIVOT IO 001 Trial ResultsAdi Diab, Helen Gogas, Shahneen Sandhu, et al.Nature Medicine|October 9, 2019
Pulmonary venous circulating tumor cell dissemination before tumor resection and disease relapseFrancesca Chemi, Dominic G Rothwell, Nicholas McGranahan, et al.Pageof 74